2nd Data Monitoring Committees Conference
Venue: The Fairmont San Francisco
|Event Date/Time: Oct 15, 2007||End Date/Time: Oct 16, 2007|
DMCs offer an opportunity for a team of experts, independent from the trial sponsor, to examine the interim clinical data and make unbiased recommendations for the continuation, alteration and termination of the trial. Incorporating DMCs into trial design and conduct adds additional protection against proceeding with an unsafe product or futile trial design which mitigates risk to subjects, optimizes resource utilization for the sponsor by reassuring study integrity and protects the public from access to unsafe products.
Please don't hesitate to contact me if you have any questions. I look forward to seeing you in October.